CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the acceptance of an abstract for oral ...

FactSet Research shows strong fundamentals, AI-driven growth, high retention, and undervaluation with global expansion upside ...

Overall, both Wall Street and Seeking Alpha analysts have a Buy rating for the stock, while it is recommended to Hold LRCX as ...

Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the ...

In September 2024, Sanofi entered an exclusive licensing agreement with Orano Med and RadioMedix to globally commercialize ...

From heart disease to neurodegeneration, Novartis makes bold deals in 2025 to expand its drug pipeline globally.

You might not have seen a case of it yet, but odds are increasing that a patient with an emerging meat allergy could present to your clinic. Alpha-gal syndrome (AGS), the tick-borne allergy to animal ...

Major stock indexes finished mixed on a busy day of corporate news Tuesday, with the Dow Jones Industrial Average setting ...

Researchers have devised a new way to illuminate the previously invisible oligomer clumps driving Parkinson’s disease.

NEW YORK, Oct 1 (Reuters) - Bridgewater Associates' main macro funds posted healthy gains in the third quarter, with its flagship Pure Alpha fund recording an 8.1% gain, aided by a robust quarter for ...

Six of the top AI LLMs are trading leveraged positions on Hyperliquid. DeepSeek's Chat V3.1 is currently leading the race with over 40% gains in ...

Researchers have achieved the first demonstration in mice of using gene therapy to reverse hallmark symptoms of ...